Investigations into the molecular mechanisms reveal that CD10 may facilitate the spread of CRC to the liver by counteracting the anti-tumor properties of hepatic methionine-enkephalin (MENK) (Kuniyasu et al., 2010). Here, MME is linked to colorectal carcinoma.